JF
Jingjing Feng

Highly Cited

105
Works
1,442
Citations
21
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Jingjing Feng

Also known as: Feng, Jingjing, J Feng, J. Feng, J. S. Feng, J.S. Feng

105

Total Works

1,442

Citations

21

H-Index

44

i10-Index

Citation & Works Trend by Year
20 years active
Top Research Topics
CAR-T cell therapy research (36) T-cell and B-cell Immunology (31) Immunotherapy and Immune Responses (17) Acute Lymphoblastic Leukemia research (14) Asthma and respiratory diseases (10)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Supplementary Table S2 from Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR T–Treated T-cell Lymphoid Malignancies 0
2026 Supplementary Table S7 from Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR T–Treated T-cell Lymphoid Malignancies 0
2026 Supplementary Table S8 from Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR T–Treated T-cell Lymphoid Malignancies 0
2026 Supplementary Table S5 from Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR T–Treated T-cell Lymphoid Malignancies 0
2026 Supplementary Table S6 from Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR T–Treated T-cell Lymphoid Malignancies 0
2026 Supplementary Table S1 from Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR T–Treated T-cell Lymphoid Malignancies 0
2026 Supplementary Figures S1-S13 from Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR T–Treated T-cell Lymphoid Malignancies 0
2026 Supplementary Table S3 from Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR T–Treated T-cell Lymphoid Malignancies 0
2026 Data from Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR T–Treated T-cell Lymphoid Malignancies 0
2026 Supplementary Table S4 from Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR T–Treated T-cell Lymphoid Malignancies 0
2026 Genetic Mutation and Epigenetic Silencing Drive Antigen-Negative Relapse in CD7 CAR T–Treated T-cell Lymphoid Malignancies Blood Cancer Discovery 0
2026 Long-Term Follow-Up of CD19 CAR-T for R/R B-NHL: Ki-67 as a Prognostic Factor for Sustained Remission Transplantation and Cellular Therapy 1
2025 Reproductive History and Age at Menarche in Relation to Reproductive Lifespan and Natural Menopause: A population-based analysis from NHANES 1999–March 2020 medRxiv 0
2025 Rituximab, lenalidomide, and zanubrutinib (ZR2) with sequential CAR-T cell as first-line therapy for high-risk large B cell lymphoma Blood 0
2025 CD7-negative T cell immune reconstitution after CD7-targted CAR-T cell therapy Blood 0

Data source: OpenAlex API